SANDOZ RABEPRAZOLE
SANDOZ CANADA INCORPORATED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of SANDOZ RABEPRAZOLE in Canada?
Yes. SANDOZ RABEPRAZOLE 20MG has an active shortage reported to Health Canada (last updated October 27, 2026).
Why is SANDOZ RABEPRAZOLE not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will SANDOZ RABEPRAZOLE be available again?
The manufacturer's estimated resolution date is December 4, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Proton Pump Inhibitor (PPI) Shortage in Canada: Omeprazole, Pantoprazole, Rabeprazole
Why a shortage of one PPI brand rarely means the whole class is unavailable, when a pharmacist can swap manufacturers, and when it needs your prescriber.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
PARIET, ENTERIC-COATED TABLET 20MG
JANSSEN INC
RABEPRAZOLE
SIVEM PHARMACEUTICALS ULC
Other Products
SANDOZ RABEPRAZOLE
SANDOZ CANADA INCORPORATED
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-12-04
~22 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02314185
Strength
20MG
Dosage Form
TABLET (ENTERIC-COATED)
Route
ORAL
Active Ingredient
RABEPRAZOLE SODIUM
Tier
Unrated
Last Updated
2026-10-27
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
SANDOZ RABEPRAZOLE has 7 shortage/discontinuation reports on file — this is one of them.
Disruption of the manufacture of the drug.
Delay in shipping of the drug.
Delay in shipping of the drug.
Disruption of the manufacture of the drug.
Disruption of the manufacture of the drug.
Requirements related to complying with good manufacturing practices.
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495937
DIN 02495910
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759